Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence for mitochondrial dysfunction is provided by mutations in genes that are associated with mitochondria in familial PD [e.g., mitochondrial kinase PINK (PTEN-induced kinase 1) and Parkin (Valente et al., 2004;Poole et al., 2008)], and features of PD are caused by mitochondrial toxins (Bove ´et al., 2005).”
From Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies (2008) · cites this paper as Valente et al., 2004
In the citing paper
“Mutations in PARKIN and PINK1 are the leading causes of autosomal recessive PD [9, 10].”
From miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1) (2016) · cites this paper as [10]
In the citing paper
“Multiple neurodegenerative diseases have dysfunctional mitophagic processes in neurons, as described in Parkinson’s disease (PD) (16), Huntington’s disease (17), amyotrophic lateral sclerosis (ALS) (18), and Alzheimer’s disease (AD) (19,20).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [16]
In the citing paper
“A causal association has been established between autosomal recessive forms of PD and mutations affecting the mitophagy regulators PINK1 (PTEN‐induced putative kinase 1) and PRKN/PARK2 (Parkin RBR E3 ubiquitin protein ligase) (Kitada et al, 1998; Valente et al, 2004; Narendra et al, 2008; Matsuda et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Valente et al, 2004
In the citing paper
“The most studied mechanism for mitophagy in mammalian cells is mediated by the cytoplasmic E3 ubiquitin ligase PARKIN [210] and the mitochondrial membrane kinase PINK1 [211].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [211]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Self-citationChen, H.-K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M. C., Orr, H. T., Botas, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00349-0 · Cited by 414
Research works printed but not linked: 1
- A. H. Schapiraet al., Lancet2, 1269 (1989).
Cited by
Items 501–600 of 1,043
Mitochondrial Dysfunction in Parkinson's Disease
Keane, P. C., Kurzawa, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson's Disease · doi:10.4061/2011/716871 · Cited by 160
Leucine-rich repeat kinase 2 associates with lipid rafts
Hatano, T., Kubo, S.-I., Imai, S., Maeda, M., Ishikawa, K., Mizuno, Y., & Hattori, N. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm013 · Cited by 176
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD
Pyle, A., Foltynie, T., Tiangyou, W., Lambert, C., Keers, S. M., Allcock, L. M., Davison, J., Lewis, S. J., Perry, R. H., Barker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20417 · Cited by 176
Mitochondrial dysfunction in Parkinson's disease
Schapira, A. H. V. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402160 · Cited by 175
Genetics and Epigenetics of Parkinson's Disease
Coppedè, F. (2012) · The Scientific World Journal · doi:10.1100/2012/489830 · Cited by 175
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
The Italian Parkinson Genetics Network, Di Fonzo, A., Tassorelli, C., De Mari, M., Chien, H. F., Ferreira, J., Rohé, C. F., Riboldazzi, G., Antonini, A., Albani, G., et al. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201539 · Cited by 174
Mitochondrial Disease—Its Impact, Etiology, and Pathology
McFarland, R., Taylor, R. W., & Turnbull, D. M. (2007) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)77005-3 · Cited by 174
Yap, T. L., Gruschus, J. M., Velayati, A., Westbroek, W., Goldin, E., Moaven, N., Sidransky, E., & Lee, J. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237859 · Cited by 174
Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea
Plun-Favreau, H., Lewis, P. A., Hardy, J., Martins, L. M., & Wood, N. W. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001257 · Cited by 173
Self-citationVPS35, the Retromer Complex and Parkinson’s Disease
Williams, E. T., Chen, X., & Moore, D. J. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-161020 · Cited by 173
Mitochondrial quality control: from molecule to organelle
Roca-Portoles, A., & Tait, S. W. G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03775-0 · Cited by 172
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress
Muqit, M. M. K., Abou‐Sleiman, P. M., Saurin, A. T., Harvey, K., Gandhi, S., Deas, E., Eaton, S., Payne Smith, M. D., Venner, K., Matilla, A., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03845.x · Cited by 173
Self-citationMei, Y., Zhang, Y., Yamamoto, K., Xie, W., Mak, T. W., & You, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901104106 · Cited by 172
Meireles, J., & Massano, J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00088 · Cited by 172
DNA repair, mitochondria, and neurodegeneration
Weissman, L., de Souza-Pinto, N. C., Stevnsner, T., & Bohr, V. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.061 · Cited by 172
Genetic mouse models of parkinsonism: Strengths and limitations
Fleming, S. M., Fernagut, P.-O., & Chesselet, M.-F. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.495 · Cited by 172
Gilkerson, R. W., De Vries, R. L. A., Lebot, P., Wikstrom, J. D., Torgyekes, E., Shirihai, O. S., Przedborski, S., & Schon, E. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr529 · Cited by 170
Identification of TMEM230 mutations in familial Parkinson's disease
Deng, H.-X., Shi, Y., Yang, Y., Ahmeti, K. B., Miller, N., Huang, C., Cheng, L., Zhai, H., Deng, S., Nuytemans, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3589 · Cited by 172
Kilarski, L. L., Pearson, J. P., Newsway, V., Majounie, E., Knipe, M. D. W., Misbahuddin, A., Chinnery, P. F., Burn, D. J., Clarke, C. E., Marion, M., et al. (2012) · Movement Disorders · doi:10.1002/mds.25132 · Cited by 170
Self-citationThe PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway
Szargel, R., Shani, V., Abd Elghani, F., Mekies, L. N., Liani, E., Rott, R., & Engelender, S. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw189 · Cited by 170
Cookson, M. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009415 · Cited by 170
“2003) had been cloned previously as an oxidative stress response protein, whereas PINK1 (Valente et al. 2004) had been identified in a microarray screen and named as “PTENinduced novel kinase 1.”
BackgroundRemondelli, P., & Renna, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00187 · Cited by 169
“Furthermore, mitochondrial damage activates an autophagy pathway named mitophagy and it is linked to neurodegenerative diseases such as PD and ALS (Valente et al., 2004; Chung et al., 2016).”
BackgroundThe Function of Autophagy in Neurodegenerative Diseases
Kiriyama, Y., & Nochi, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125990 · Cited by 167
The genetics of Parkinson disease: implications for neurological care
Klein, C., & Schlossmacher, M. G. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0126 · Cited by 168
Reinders, J., Wagner, K., Zahedi, R. P., Stojanovski, D., Eyrich, B., van der Laan, M., Rehling, P., Sickmann, A., Pfanner, N., & Meisinger, C. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700098-mcp200 · Cited by 169
Liu, X., Cheng, R., Verbitsky, M., Kisselev, S., Browne, A., Mejia-Sanatana, H., Louis, E. D., Cote, L. J., Andrews, H., Waters, C., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-104 · Cited by 168
Update on the genetics of Parkinson's disease
Gasser, T. (2007) · Movement Disorders · doi:10.1002/mds.21676 · Cited by 168
Chu, C. T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq143 · Cited by 166
An updated review of Parkinson's disease genetics and clinicopathological correlations
Ferreira, M., & Massano, J. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12616 · Cited by 167
Parkin and PINK1 functions in oxidative stress and neurodegeneration
Barodia, S. K., Creed, R. B., & Goldberg, M. S. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.12.004 · Cited by 167
Vaz, R. L., Outeiro, T. F., & Ferreira, J. J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00347 · Cited by 166
p62/ SQSTM1 and Selective Autophagy in Cardiometabolic Diseases
Jeong, S.-J., Zhang, X., Rodriguez-Velez, A., Evans, T. D., & Razani, B. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7649 · Cited by 165
Targeting mitophagy in neurodegenerative diseases
Antico, O., Thompson, P. W., Hertz, N. T., Muqit, M. M. K., & Parton, L. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01105-0 · Cited by 160
Self-citationWeihofen, A., Ostaszewski, B., Minami, Y., & Selkoe, D. J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm334 · Cited by 165
Gasser, T., Hardy, J., & Mizuno, Y. (2011) · Movement Disorders · doi:10.1002/mds.23637 · Cited by 166
“The PINK1 gene contains 8 exons encoding a mitochondrial protein composed of 581 amino acids.(56) Many missense and nonsense mutations and rare deletion mutations were reported.”
BackgroundThe potential role of neuroinflammation and transcription factors in Parkinson disease
Tiwari, P. C., & Pal, R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.1/rpal · Cited by 164
Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease
McNaught, K. S. P., & Olanow, C. W. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.012 · Cited by 165
A heterozygous effect for PINK1 mutations in Parkinson's disease?
Abou‐Sleiman, P. M., Muqit, M. M. K., McDonald, N. Q., Yang, Y. X., Gandhi, S., Healy, D. G., Harvey, K., Harvey, R. J., Deas, E., Bhatia, K., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20960 · Cited by 166
Self-citationWhy size matters – balancing mitochondrial dynamics in Alzheimer's disease
DuBoff, B., Feany, M., & Götz, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.002 · Cited by 165
Fai Poon, H., Frasier, M., Shreve, N., Calabrese, V., Wolozin, B., & Butterfield, D. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.009 · Cited by 165
Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease
Gao, H.-M., & Hong, J.-S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.005 · Cited by 165
Molecular diagnostics of neurodegenerative disorders
Agrawal, M., & Biswas, A. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00054 · Cited by 164
“This finding provided additional evidence that PINK1 mutations are associated with PARK6 (Valente et al., 2004).”
BackgroundReciprocal Roles of Tom7 and OMA1 during Mitochondrial Import and Activation of PINK1
Sekine, S., Wang, C., Sideris, D. P., Bunker, E., Zhang, Z., & Youle, R. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.002 · Cited by 164
Biology of Mitochondria in Neurodegenerative Diseases
Martin, L. J. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00005-9 · Cited by 163
Perfeito, R., Cunha-Oliveira, T., & Rego, A. C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.042 · Cited by 164
Arena, G., Gelmetti, V, Torosantucci, L., Vignone, D., Lamorte, G., De Rosa, P., Cilia, E., Jonas, E. A., & Valente, E. M. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.19 · Cited by 164
Self-citationAutophagy in Cell Life and Cell Death
Anding, A. L., & Baehrecke, E. H. (2015) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2015.07.012 · Cited by 163
Postural Instability in Parkinson’s Disease: A Review
Palakurthi, B., & Burugupally, S. P. (2019) · Brain Sciences · doi:10.3390/brainsci9090239 · Cited by 163
Kim, J., Fiesel, F. C., Belmonte, K. C., Hudec, R., Wang, W.-X., Kim, C., Nelson, P. T., Springer, W., & Kim, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0121-4 · Cited by 172
“Mutations in PARKIN and PINK1 are the leading causes of autosomal recessive PD [9, 10].”
BackgroundAutophagy, polyphenols and healthy ageing
Pallauf, K., & Rimbach, G. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.03.008 · Cited by 164
Parkinson's disease: insights from pathways
Cookson, M. R., & Bandmann, O. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq167 · Cited by 162
Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention
Ho, G.-T., & Theiss, A. L. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-060821-083306 · Cited by 160
Signaling and Regulation of the Mitochondrial Unfolded Protein Response
Naresh, N. U., & Haynes, C. M. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033944 · Cited by 161
Using zebrafish to assess the impact of drugs on neural development and function
Guo, S. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902988464 · Cited by 160
Selective escape of proteins from the mitochondria during mitophagy
Saita, S., Shirane, M., & Nakayama, K. I. (2013) · Nature Communications · doi:10.1038/ncomms2400 · Cited by 161
Synaptic dysfunction in Parkinson's disease
Bagetta, V., Ghiglieri, V., Sgobio, C., Calabresi, P., & Picconi, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380493 · Cited by 160
Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson’s-like movement disorder
Lu, W., Karuppagounder, S. S., Springer, D. A., Allen, M. D., Zheng, L., Chao, B., Zhang, Y., Dawson, V. L., Dawson, T. M., & Lenardo, M. (2014) · Nature Communications · doi:10.1038/ncomms5930 · Cited by 161
Mendelian forms of Parkinson's disease
Gasser, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.007 · Cited by 161
Haddad, D., & Nakamura, K. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.021 · Cited by 160
Mitochondrial DNA mutations in neurodegeneration
Keogh, M. J., & Chinnery, P. F. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.015 · Cited by 161
Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models
Hsieh, C.-H., Li, L., Vanhauwaert, R., Nguyen, K. T., Davis, M. D., Bu, G., Wszolek, Z. K., & Wang, X. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.023 · Cited by 157
Periquet, M., Corti, O., Jacquier, S., & Brice, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03442.x · Cited by 160
Exosomes and stem cells in degenerative disease diagnosis and therapy
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C. (2018) · Cell Transplantation · doi:10.1177/0963689717723636 · Cited by 159
Neuroimmune Connections in Aging and Neurodegenerative Diseases
Scheiblich, H., Trombly, M., Ramirez, A., & Heneka, M. T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.02.002 · Cited by 166
Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
Perier, C., Bové, J., & Vila, M. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4074 · Cited by 158
Energy Failure: Does It Contribute to Neurodegeneration?
Pathak, D., Berthet, A., & Nakamura, K. (2013) · Annals of Neurology · doi:10.1002/ana.24014 · Cited by 159
MANDEL, S., GRUNBLATT, E., RIEDERER, P., AMARIGLIO, N., HIRSCH, J. J., RECHAVI, G., & YOUDIM, M. B. H. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00044.x · Cited by 158
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression
Gasser, T. (2011) · The Application of Clinical Genetics · doi:10.2147/tacg.s11639 · Cited by 157
Mitophagy: the latest problem for Parkinson's disease
Vives-Bauzá, C., & Przedborski, S. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.002 · Cited by 171
The association between Parkinson's disease and melanoma
Pan, T., Li, X., & Jankovic, J. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.25912 · Cited by 164
Marongiu, R., Spencer, B., Crews, L., Adame, A., Patrick, C., Trejo, M., Dallapiccola, B., Valente, E. M., & Masliah, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05932.x · Cited by 156
Self-citationAnimal models of the non-motor features of Parkinson's disease
McDowell, K., & Chesselet, M.-F. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.040 · Cited by 156
Proteasome system of protein degradation and processing
Sorokin, A. V., Kim, E. R., & Ovchinnikov, L. P. (2009) · Biochemistry (Moscow) · doi:10.1134/s000629790913001x · Cited by 156
Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y
Deng, H., Jankovic, J. J., Guo, Y., Xie, W., & Le, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.178 · Cited by 175
Yu, W. H., Dorado, B., Figueroa, H. Y., Wang, L., Planel, E., Cookson, M. R., Clark, L. N., & Duff, K. E. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080928 · Cited by 155
Parkinson's disease and cancer: two wars, one front
Devine, M. J., Plun‐Favreau, H., & Wood, N. W. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3150 · Cited by 169
Self-citationBhandari, P., Song, M., Chen, Y., Burelle, Y., & Dorn, G. W. (2014) · Circulation Research · doi:10.1161/circresaha.114.302734 · Cited by 155
Huang, M., Chiang, S., Kalinowski, D. S., Bae, D.-H., Sahni, S., & Richardson, D. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6392763 · Cited by 169
Burtscher, J., Millet, G. P., Place, N., Kayser, B., & Zanou, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126479 · Cited by 170
Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease
Luoma, P. T., Eerola, J., Ahola, S., Hakonen, A. H., Hellström, O., Kivistö, K. T., Tienari, P. J., & Suomalainen, A. (2007) · Neurology · doi:10.1212/01.wnl.0000276955.23735.eb · Cited by 154
Redox Control of the Survival of Healthy and Diseased Cells
Zhang, Y., Du, Y., Le, W., Wang, K., Kieffer, N., & Zhang, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3685 · Cited by 153
Carroll, R. G., Hollville, E., & Martin, S. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.046 · Cited by 154
PINK1 function in health and disease
Deas, E., Plun‐Favreau, H., & Wood, N. W. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900024 · Cited by 154
Self-citationUse of Calcium Channel Blockers and Parkinson’s Disease
Pasternak, B., Svanström, H., Nielsen, N. M., Fugger, L., Melbye, M., & Hviid, A. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr362 · Cited by 154
A Futile Battle? Protein Quality Control and the Stress of Aging
Higuchi‐Sanabria, R., Frankino, P. A., Paul, J. W., Tronnes, S. U., & Dillin, A. G. (2018) · Developmental Cell · doi:10.1016/j.devcel.2017.12.020 · Cited by 163
PMI: A ΔΨm Independent Pharmacological Regulator of Mitophagy
East, D. A., Fagiani, F., Crosby, J., Georgakopoulos, N. D., Bertrand, H., Schaap, M., Fowkes, A., Wells, G., & Campanella, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.019 · Cited by 152
Protective effect against Parkinson's disease-related insults through the activation of XBP1
Sado, M., Yamasaki, Y., Iwanaga, T., Onaka, Y., Ibuki, T., Nishihara, S., Mizuguchi, H., Momota, H., Kishibuchi, R., Hashimoto, T., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.104 · Cited by 171
Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons
Evans, C. S., & Holzbaur, E. L. (2020) · eLife · doi:10.7554/elife.50260 · Cited by 137
“Mitophagy is primarily regulated by two proteins linked to familial PD, PTEN-Induced Putative Kinase 1 (PINK1) and Parkin (Kitada et al., 1998; Narendra et al., 2008; Narendra et al., 2010b; Valente et al., 2004; Wang and Klionsky, 2011; Youle and Narendra, 2011).”
BackgroundDysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
Selective sorting and destruction of mitochondrial membrane proteins in aged yeast
Hughes, A. L., Hughes, C. E., Henderson, K. A., Yazvenko, N., & Gottschling, D. E. (2016) · eLife · doi:10.7554/elife.13943 · Cited by 152
Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Lau, K., Kotzur, R., & Richter, F. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00430-z · Cited by 187
Gu, Z., Nakamura, T., & Lipton, S. A. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8113-9 · Cited by 151
Endocytic membrane trafficking and neurodegenerative disease
Schreij, A. M. A., Fon, E. A., & McPherson, P. S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2105-x · Cited by 162
Invited Review: The role of prion‐like mechanisms in neurodegenerative diseases
Jaunmuktane, Z., & Brandner, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12592 · Cited by 150
Pagliarini, D. J., Wiley, S. E., Kimple, M. E., Dixon, J. R., Kelly, P., Worby, C. A., Casey, P. J., & Dixon, J. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.008 · Cited by 158
New Insights into Toxicity and Drug Testing
(2013) · InTech eBooks · doi:10.5772/55886 · Cited by 149
Scott, J. D., DeMong, D. E., Greshock, T. J., Basu, K., Dai, X., Harris, J., Hruza, A., Li, S. W., Lin, S.-I., Liu, H., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00045 · Cited by 143
MitophAging: Mitophagy in Aging and Disease
Bakula, D., & Scheibye-Knudsen, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00239 · Cited by 148
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Ma, L., Gholam Azad, M., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101896 · Cited by 148
Kotzbauer, P. T., Truax, A. C., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4265-04.2005 · Cited by 148
Metadata
- Authors
- Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G., & Wood, N. W.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- CSS IRCCS, Mendel Institute, viale Regina Margherita 261, 00198 Rome, Italy.
- Goethe University Frankfurt (DE)
- Università Cattolica del Sacro Cuore (IT)
- National Institutes of Health (US)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Valente, Enza Maria
- ORCID
- Venue
- Science
- Published
- 2004-05-21
- Volume
- 304
- Issue
- 5674
- Pages
- 1158-1160
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2136388422
- Cited by
- 3,481
- References
- 19
- Citations by year
- 2026: 101 · 2025: 140 · 2024: 168 · 2023: 133 · 2022: 158 · 2021: 187 · 2020: 182 · 2019: 158 · 2018: 167 · 2017: 189 · 2016: 147 · 2015: 151 · 2014: 158 · 2013: 177 · 2012: 163
- FWCI
- 109.31
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Parkinson's UK (G-4029)
- Brain Research Trust
- Deutsche Forschungsgemeinschaft
- Ministero della Salute
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, PINK1, mitochondrial dysfunction, dopaminergic neuron loss, consanguineous family, nonsense mutation, missense mutations, mitochondrial localization
- MeSH terms
- PTEN-Induced Putative Kinase, Amino Acid Sequence, Animals, Exons, Humans, Leupeptins, Membrane Potentials, Mitochondria, Molecular Sequence Data, Mutation, Neurons, Parkinson Disease, Protein Kinases, Transfection, Apoptosis, Protein Structure, Tertiary, Oxidative Stress, Codon, Nonsense, COS Cells, Mutation, Missense, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.